Correlation Between NYSE Composite and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Seres Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Seres Therapeutics.
Diversification Opportunities for NYSE Composite and Seres Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between NYSE and Seres is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Seres Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Seres Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.16 times less return on investment than Seres Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 10.28 times less risky than Seres Therapeutics. It trades about 0.42 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 84.00 in Seres Therapeutics on November 2, 2024 and sell it today you would earn a total of 2.00 from holding Seres Therapeutics or generate 2.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Seres Therapeutics
Performance |
| Timeline |
NYSE Composite and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Seres Therapeutics
Pair trading matchups for Seres Therapeutics
Pair Trading with NYSE Composite and Seres Therapeutics
The main advantage of trading using opposite NYSE Composite and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| NYSE Composite vs. Western Copper and | NYSE Composite vs. Chemours Co | NYSE Composite vs. IPG Photonics | NYSE Composite vs. Morgan Advanced Materials |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |